Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients

Amyloid

Volumn 18, Issue 4, 2011, Pages 200-205

  Okamoto, Sadahisa ^a,b   Zhao, Ying ^c,d   Lindqvist, Per ^c   Backman, Christer ^c   Ericzon, Bo Göran ^e   Wijayatunga, Priyantha ^c   Henein, Michael Y ^c   Suhr, Ole B ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UMEÅ UNIVERSITY   (Sweden)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloidosis hereditary neuropathic; Cardiomyopathy hypertrophic; Senescence; Transplantation liver; Transthyretin

Indexed keywords

PREALBUMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOMYOPATHY; CLINICAL PROTOCOL; DISEASE COURSE; DISEASE DURATION; ECHOCARDIOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; GENE MUTATION; HEART VENTRICLE SEPTUM; HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE FACTORS; AGED; AMYLOIDOSIS, FAMILIAL; BLOOD PRESSURE; CARDIOMYOPATHIES; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SWEDEN; VENTRICULAR SEPTUM;

EID: 81255201282     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.615872     Document Type: Article

References (33)

1. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495-1504. (Pubitemid 30420948)
2. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113-1116. (Pubitemid 23125854)
3. Parrilla P, Ramirez P, Andreu LF, Bueno SF, Robles R, Miras M, Acosta F, et al. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997;64:646-649. (Pubitemid 27377199)
4. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002;8:787-794. Figure 3. Recordings of the interventricular septum thickness of the 42 patients evaluated at the long-term post-LTx evaluation in relation to pre-LTx findings and age at onset of the disease. (Pubitemid 35012288)
5. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037-1038. (Pubitemid 26360371)
6. Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520-524.
7. Hornsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112-116.
8. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74-80. (Pubitemid 27327203)
9. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233. (Pubitemid 28370006)
10. Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006;85:229-238. (Pubitemid 44107181)
11. Okamoto S, Yamashita T, Ando Y, Ueda M, Misumi Y, Obayashi K, Horibata Y, Uchino M. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation. Intern Med 2008;47:2133-2137.
12. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73: 745-751. (Pubitemid 34260571)
13. Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei YI, Koyama J, Kawamorita A, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235-242. (Pubitemid 44952878)
14. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479-485. (Pubitemid 24212814)
15. Hornsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: Impact of age and gender. Amyloid 2010;17:63-68.
16. Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol 2008;216:253-261.
17. Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999;122 (Pt 10):1951-1962. (Pubitemid 29473866)
18. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881-1891. (Pubitemid 38748646)
19. Jacobson DR, Pastore R, Pool S, Malendowicz S, Kane I, Shivji A, Embury SH, et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996;98:236-238. (Pubitemid 26237513)
20. Ranlov I, Alves IL, Ranlov PJ, Husby G, Costa PP, Saraiva MJ. A Danish kindred with familial amyloid cardiomyopathy revisited: Identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med 1992;93:3-8.
21. Morner S, Hellman U, Suhr OB, Kazzam E, Waldenstrom A. Amyloid heart disease mimicking hypertrophic cardiomyopathy. J Intern Med 2005;258:225-230. (Pubitemid 41243053)
22. Olofsson BO, Andersson R, Furberg B. Atrioventricular and intraventricular conduction in familial amyloidosis with polyneuropathy. Acta Med Scand 1980;208:77-80.
23. Nowak G, Suhr OB, Wikstrom L, Wilczek H, Ericzon BG. The longterm impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients. Transpl Int 2005;18:111-115. (Pubitemid 41742954)
24. Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, Gjertsen H, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): A single-center experience over 16 years. Am J Transplant 2007;7:2597-2604. (Pubitemid 47561612)
25. Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, Uchino M, Suhr OB. Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transpl 2009;15:1229-1235.
26. Rapezzi C, Riva L, Quarta CC, Perugini E, Salvi F, Longhi S, Ciliberti P, et al. Gender-related risk of myocardial involvement in systemic amyloidosis. Amyloid 2008;15:40-48. (Pubitemid 351238493)
27. Goncalves I, Alves CH, Quintela T, Baltazar G, Socorro S, Saraiva MJ, Abreu R, Santos CR. Transthyretin is up-regulated by sex hormones in mice liver. Mol Cell Biochem 2008;317:137-142.
28. Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277-282. (Pubitemid 350035574)
29. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702-706. (Pubitemid 30663682)
30. Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations. Amyloid 2003;10:48-54. (Pubitemid 37372567)
31. Koike H, Ando Y, Ueda M, Kawagashira Y, Iijima M, Fujitake J, Hayashi M, et al. Distinct characteristics of amyloid deposits in earlyand late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009;287:178-184.
32. Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 2011;89:171-180.
33. Suhr OB, Andersen O, Aronsson T, Jonasson J, Kalimo H, Lundahl C, Lundgren HE, et al. Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden. Amyloid 2009;16:208-214.